Breast Cancer Flashcards

1
Q

Breast Cancer Risk Factors

A
  • Hormonal factors
  • Increasing age
  • CA of contralateral breast/endometrium
  • Radiation exposure
  • Genetic susceptibility
  • Diet
  • Proliferative breast disease
  • Males w/ Klinefelter’s
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

BRCA 1 and 2

A
  • Breast cancer susceptibility genes
  • Tumor suppressor genes
  • Mutations of these genes predispose to breast, ovarian and even prostate cancer
  • BRCA2- male breast cancer
  • Ashkenazi (Eastern European) Jewish pop.
  • Minority of breast cancer cases actually due to these mutationsd
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

HER2 Gene

A
  • Breast Cancer susceptibility gene
  • Oncogene, encodes transmembrane growth factor receptor
  • Cytoplasmic tyrosine kinase is overexpressed and causes cell division
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Majority of breast cancers are what type?

A
  • ER positive
  • HER2 neg.
  • 50-65% of cancers
  • “Luminal” type
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Types of breats cancers

A
  • ER pos., HER2 neg. (50-65%)

*“Luminal”

  • HER2 pos. (20%)

*“HER2 enriched”

  • ER neg. HER2 neg. (15%)

*“Basal-like”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Breast Quadrants Relationship w/ Cancer

A
  • Symptoms:

*breast lumps

*nipple abnormalities

*discomfort

  • Most breast cancer occurs in the upper outer quadrant
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Symptoms of breast disease and presentations of breast cancer pie graph

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Breast Cancer Mammography

A

Maligant lesions tend to be:

  • Stellate and circular w/o calcifications (64%)
  • Stellate and circular w/ calcifications (17%)
  • Calcifications only (19%)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Myoepithelial Cells

A
  • Surround glandular acini and help express secretory product into duct system
  • Tend to be lost in invasive carcinoma
  • Lesions that remain within the myoepithelial border are “in situ” and have not yet broke through
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Most Breast Cancer Originate in the

A
  • Terminal duct lobular unit
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Ductal carcinoma in situ

A
  • Age 50-60

- Neoplasia limited to epithelium

*neoplastic cells confined to ducts, expanding them, but not breaking into surrounding stroma

*may have central “comedo” necrosis

  • Progression to invasive carcinoma is based on nuclear grade

*8-10x compared to general pop.

*evolution to invasive disease is unpredictable

  • Accounts for 15-30% of all breast carcinoma
  • Usually multifocal
  • Excision recommended, sometimes radiation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Ductal carcinoma in situ vs. Ductal carcinoma histology

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Ductal carcinoma

A
  • Largest group of invasive breast cancers, accounting for 40-75%
  • Grossly white-tan, firm, often stellate, causing puckering of surrounding tissue
  • Type of adenocarcinoma in that its a glandular carcinoma presenting w/ irregularity of glands
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Ductal carcinoma histological forms

A
  • Cords, clusters, trabeculae, or solid
  • Abundant cytoplasm
  • Nuclei can be regular or pleomorphic
  • Most cases have assoc. ductal carcinoma in situ
  • Mitotic figures +/-
  • Necrosis +/-
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Metastatic ductal carcinoma histology

A
  • “Cannonball” in pleural fluid typical of most metastatic adenocarcinomas
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Lobular carcinoma in situ

A
  • Avg age 53
  • Present in 0.5 - 8% of benign breast biopsies

*usually not assoc. w/ microcalcifications

*risk of invasive lobular carcinoma after LCIS is 5x risk

  • Watchful waiting
  • If strong family history of carcinoma, can consider ipsilateral or B/L mstectomy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

DCIS vs LCIS

A
  • Distinguishing b/w DCIS and LCIS can be difficult
  • E-cadherin stain:

*calcium-dependent transmebrane epithelial protein that promotes intercellular adhesion (makes cells stickier)

*abnormal function in carcinomas may facilitate detachment leading to metastasis

  • Cells that express E-cadherin are less likely to metastasize b/c they’re stuck and are more cohesive
  • Cells that dont have E-cadherin are more likely to metastasize

- DCIS stains strongly w/ E-cadherin, LCIS does not

18
Q

Lobular Carcinoma

A
  • 5-15% of all breast cancers
  • 10-20% are B/L
  • Often not well seen on mammograms
  • Metastasizes to bone marrow, cerebrospinal fluid and leptomeninges GI tract, ovary, serosal surfaces, uterus more than other subtypesd
19
Q

Lobular Carcinoma Histology

A
  • Tends to form single file or targetoid streaming of the cells
  • Cells may have intracytoplasmic mucin
  • On E-cadherin staining, invasive lobular carcinoma will be evidenced by a lack of dye uptake
  • Can have a signet ring variant where the nucleus looks like its being pushed up to the side

*tends to be more aggressive

20
Q

Male Breast Cancer Characteristics

A
  • BRCA2 mutation
  • Usually ductal, as males often lack lobules or have atrophic lobules
  • More likely to invade chest wall (less fat in breast)
21
Q

Mucinous Carcinoma (aka colloid carcinoma)

A
  • Well-circumscribed, crepitant to palpation
  • Postmenopausal women
  • Clusters of tumor cells floating in mucin
  • Low incidence of metastasis
  • Excellent short-term prognosis, but late recurrences
22
Q

Apocrine Carcinoma

A
  • Rare, 1-4% of all breast carcinomas
  • Prognosis similar to ductal carcinoma
  • Tumor cells have distinct cell margins, eosinophilic, granular cytoplasm, round nuclei, prominent nucleoli
  • Glandular differentiation w/ apocrine snouts
23
Q

Secretory Carcinoma

A
  • Rare, primarily in children
  • Well-circumscribed, small
  • “Pushing margins”
  • Vacuolated cytoplasm forming lumina containing eosinophilic secretions
  • Excellent prognosis w/ 100% 5yr survival
24
Q

Metaplastic Carcinoma

A
  • Ductal carcinoma w/ sarcoma-like stroma
  • Cartilagenous and/or osseous areas
  • Very aggressive, hematogenous mets
25
Q

Inflammatory Breast Cancer*

A
  • Peau de orange (orange peel apperance)
  • Redness, edema and induration from dermal lymphatic invasion
  • Usually does not involve nipple (unlike Paget’s)
  • Poor prognosis

*Take breat irritation in an older woman very seriously

26
Q

Inflammatory Breast Cancer Histology

A
27
Q

Paget’s Disease

A
  • Crusted lesion of nipple caused by DCIS
  • Often accompanied by invasive carcinoma, usually HER-2+
  • Large, clear cells in epidermis
28
Q

Malignant Phyllodes Tumor

A
  • 10% of phyllodes tumors
  • Rare under age 20
  • Aggressive w/ local recurrence and metastasis
  • Better prognosis than invasive ductal carcinoma
29
Q

Malignant Phyllodes Tumor Histology

A
  • Arborizing similar to fibradenoma, but w/ stromal overgrowth
  • Sarcomatous elements
30
Q

Angiosarcoma*

A
  • Rare, <0.2% of primary breast tumors
  • Women 5-10 yrs post-radiation therapy for breast carcinoma
  • Chronically edematous arm after axillary lymph node dissection
  • Median survival 3-6yrs
31
Q

Angiosarcoma Histology

A
  • Anastomsing vascular channels lined by atypical endothelial cells w/ pleomorphic, hyperchromatic nuclei
  • Infiltrative margins
  • Variable mitotic activity
  • Typically high grade
32
Q

Prognostic factors

A
  • Sentinel lymph nodes
  • Molecular profiles:

*estrogen and progesterone receptors

*ploidy

*HER2/neu

33
Q

Sentinel lymph node staining

A
  • Cytokeratin stain shows cluster of malignant epithelial cells in a lymph node
  • Neg. sentel nodes = no axillary node dissection
34
Q

Estrogen and progesterone receptors relationship to breast cancer

A
  • Expressed by benign breast epithelial cells and over half of breast cancers
  • Rectpros can bind estrogen and progesterone—> cell growth

- Expression- older women w/ lower grade tumors, better prognosis

  • Better response to anti-estrogenic therapy or oophorectomy
35
Q

Tamoxifen

A
  • Drug w/ anti-estrogen effect useful for estrogen receptor expressing breast lesions
36
Q

Male breast cancer is more commonly assoc. w/ what gene mutation?

A
  • BRCA 2
37
Q

What gene mutation is assoc. w/ breast cancers that are poorly differentiated and triple neg. (no estrogen, progesterone or HER-2 receptors)?

A
  • BRCA1
38
Q

Trastuzmab (Herceptin)

A
  • Drug that can treat HER2-pos. breast cancers
  • Reduces metastasis, recurrence and mortality
39
Q

Poor prognostic factors

A
  • High stage

*tumor size

*nodal and distant metastases

  • High histologic grade
  • Younger age
  • Skin invasion
  • Nipple invasion
  • Angiolymphatic invasion
40
Q

Luminal tumor expression

A
  • Usually express Estrogen Receptors and/or Progesterone Receptors
  • Mostly HER2 neg.
  • Mostly low cell division (low Ki67)
41
Q

Prognosis by histologic type

A

Favorable

  • Tubular
  • Cribiform
  • Medullary
  • Colloid
  • Papillary
  • Adenoid cystic and secretory/juvenile

Unfavorable

  • Signet ring
  • Basal-like
  • Inflammatory
42
Q

Mimics of breast cancer

A
  • Present as a lump
  • Examples:

*fibroadenoma

*Intraductal papilloma (may present w/ bloody nipple discharge)

*Lactating adenoma (beward of pregnancy related breast changes)

*Sclerosing adenosis

*Radial scar

*Traumatic fat necrosis